Pharmaceuticals & Biotechnology (4570)

21,870.27
   
  • 52 Week High: 24,649.93
  • 52 Week Low: 18,687.04

Latest ShareCast News

Faron secures FDA pathway for lead cancer therapy

By Josh White

Date: Monday 18 Aug 2025

(Sharecast News) - Faron Pharmaceuticals said on Monday that it has secured a clear regulatory pathway for the potential approval of its lead cancer therapy bexmarilimab, following positive feedback from the US Food and Drug Administration.

Pharmaceuticals & Biotechnology Regulatory News

Holding(s) in Company 18-Aug-2025 15:44 RNS
Director/PDMR Shareholding 18-Aug-2025 15:00 RNS
Notice of Results 18-Aug-2025 07:00 RNS
Commercial Progress in USA 18-Aug-2025 07:00 RNS
Contract extension with global pharma partner 18-Aug-2025 07:00 RNS

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are end of day values only.

 

Price Data

Price 21,870.27
Closing Price Change 252.75
% Change 1.17 %
18-Aug-25 Close 21,870.27

Top Risers

Price Change
SAR 23.00p +17.9%
STX 6.50p +15.0%
OBI 18.00p +10.8%
OPTI 13.00p +10.6%
CIZ 1.40p +7.7%
AVCT 50.70p +5.6%
ANIC 7.90p +5.3%
HELD 0.99p +4.2%
ANP 422.00p +4.2%
FARN 217.50p +3.6%

Top Fallers

Price Change
OVB 1.05p -9.1%
CHLL 1.35p -6.9%
SVNS 0.33p -4.4%
SBTX 13.88p -3.5%
HCM 235.00p -3.3%
FUM 9.44p -2.7%
4BB 890.00p -1.1%
GENF 0.62p -0.8%
ONT 209.80p -0.3%
ANCR 265.00p -0.0%

Top of Page